| Beth E Lapka, MD | |
|
1305 W 18th St, Sioux Falls, SD 57105-0401 | |
| (605) 333-1000 | |
| Not Available |
| Full Name | Beth E Lapka |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1305 W 18th St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497765937 | NPI | - | NPPES |
| 6004440 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4909 (South Dakota) | Primary |
| Entity Name | Sanford Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821017880 PECOS PAC ID: 8325950215 Enrollment ID: O20040115000388 |
News Archive
Ambulance crews are to gain a crucial new tool to help them get speedy access to information on everything from advice on resuscitation drugs doses, to data on toxic chemicals and poisons thanks to a new Ambulance Crew Electronic Pocket Guide for Personal Digital Assistants, designed by the University of Warwick, being launched at the Ambulance Service Association Conference (AMBEX) in Harrogate on 27th -29th June.
Aeterna Zentaris Inc. and Yakult Honsha Co., Ltd. today announced the signing of an exclusive development, commercialization and licensing agreement for the development, registration and marketing of perifosine, Aeterna Zentaris' lead anti-cancer compound, for Japan.
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fourth scheduled safety analysis and recommended that the trial continue per the protocol.
The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Beth E Lapka, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: (605) 328-6548 | Beth E Lapka, MD 1305 W 18th St, Sioux Falls, SD 57105-0401 Ph: (605) 333-1000 |
News Archive
Ambulance crews are to gain a crucial new tool to help them get speedy access to information on everything from advice on resuscitation drugs doses, to data on toxic chemicals and poisons thanks to a new Ambulance Crew Electronic Pocket Guide for Personal Digital Assistants, designed by the University of Warwick, being launched at the Ambulance Service Association Conference (AMBEX) in Harrogate on 27th -29th June.
Aeterna Zentaris Inc. and Yakult Honsha Co., Ltd. today announced the signing of an exclusive development, commercialization and licensing agreement for the development, registration and marketing of perifosine, Aeterna Zentaris' lead anti-cancer compound, for Japan.
Vical Incorporated today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fourth scheduled safety analysis and recommended that the trial continue per the protocol.
The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.
› Verified 7 days ago
Arleigh Trainor, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1305 W 18th St, Sioux Falls, SD 57105 Phone: 605-333-1000 | |
Nathan Scott Elg, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-4767 | |
Dr. Scott Gregory Vankeulen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1305 W 18th St, Sioux Falls, SD 57105 Phone: 605-333-6688 Fax: 605-333-1578 | |
Donald J Kosiak Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 E 21st St, Emergency Dept, Sioux Falls, SD 57105 Phone: 605-322-2000 Fax: 605-322-2036 | |
Jessica Rae Tonsager, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-2000 | |
Dr. Peter W Levasseur, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-8000 | |
Dr. Lucas Paul Mailander, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-8000 |